BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22452449)

  • 1. Challenging symptoms in children with rare life-limiting conditions: findings from a prospective diary and interview study with families.
    Malcolm C; Hain R; Gibson F; Adams S; Anderson G; Forbat L
    Acta Paediatr; 2012 Sep; 101(9):985-92. PubMed ID: 22452449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A relational understanding of sibling experiences of children with rare life-limiting conditions: findings from a qualitative study.
    Malcolm C; Gibson F; Adams S; Anderson G; Forbat L
    J Child Health Care; 2014 Sep; 18(3):230-40. PubMed ID: 23754839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenging symptom profiles of life-limiting conditions in children: a survey of care professionals and families.
    Malcolm C; Forbat L; Anderson G; Gibson F; Hain R
    Palliat Med; 2011 Jun; 25(4):357-64. PubMed ID: 21228088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Hurler and Sanfilippo syndrome in a sibling pair.
    Sun A; Hopwood JJ; Thompson J; Cederbaum SD
    Mol Genet Metab; 2011 Jun; 103(2):135-7. PubMed ID: 21393040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucopolysaccharidosis type III (Sanfilippo disease) in Sweden: clinical presentation of 22 children diagnosed during a 30-year period.
    Malm G; Månsson JE
    Acta Paediatr; 2010 Aug; 99(8):1253-7. PubMed ID: 20337777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mucopolysaccharidoses. New therapeutic possibilities increase the need of early diagnosis].
    Malm G; Bondeson ML; von Döbeln U; Månsson JE
    Lakartidningen; 2002 Apr; 99(16):1804-9. PubMed ID: 12043480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging behavior in mucopolysaccharidoses types I-III and day-to-day coping strategies: a cross sectional explorative study.
    Hoffmann F; Hoffmann S; Kunzmann K; Ries M
    Orphanet J Rare Dis; 2020 Oct; 15(1):275. PubMed ID: 33008435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parents' experiences of living with, and caring for children, adolescents and young adults with Mucopolysaccharidosis (MPS).
    Somanadhan S; Larkin PJ
    Orphanet J Rare Dis; 2016 Oct; 11(1):138. PubMed ID: 27724940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia.
    Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ben Turkia H; Miled A; Laradi S
    Pathol Biol (Paris); 2009 Jul; 57(5):392-7. PubMed ID: 18584975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Musculoskeletal manifestations of Sanfilippo Syndrome (mucopolysaccharidosis type III).
    White KK; Karol LA; White DR; Hale S
    J Pediatr Orthop; 2011; 31(5):594-8. PubMed ID: 21654471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis.
    Murgasova L; Jurovcik M; Jesina P; Malinova V; Bloomfield M; Zeman J; Magner M
    Int J Pediatr Otorhinolaryngol; 2020 Aug; 135():110137. PubMed ID: 32502916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types I and III): potential causes and implications.
    Kuiper GA; Meijer OLM; Langereis EJ; Wijburg FA
    Orphanet J Rare Dis; 2018 Jan; 13(1):2. PubMed ID: 29310675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical rating scale for Batten disease: reliable and relevant for clinical trials.
    Marshall FJ; de Blieck EA; Mink JW; Dure L; Adams H; Messing S; Rothberg PG; Levy E; McDonough T; DeYoung J; Wang M; Ramirez-Montealegre D; Kwon JM; Pearce DA
    Neurology; 2005 Jul; 65(2):275-9. PubMed ID: 16043799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild Sanfilippo syndrome: a further cause of hyperactivity and behavioural disturbance.
    Wraith JE; Danks DM; Rogers JG
    Med J Aust; 1987 Nov; 147(9):450-1. PubMed ID: 3118155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mucopolysaccharidosis].
    Gajdos A
    Nouv Presse Med; 1977 May; 6(20):1745-6. PubMed ID: 141039
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mucopolysaccharide storage diseases. II. Possibilities and problems in diagnostic typing as seen in patients in a pediatric hospital].
    Hässler A; Kirchner M; Friedrich H; Machill G
    Kinderarztl Prax; 1980 Sep; 48(9):455-70. PubMed ID: 6776332
    [No Abstract]   [Full Text] [Related]  

  • 17. Sleep disturbance in Sanfilippo syndrome: a parental questionnaire study.
    Fraser J; Gason AA; Wraith JE; Delatycki MB
    Arch Dis Child; 2005 Dec; 90(12):1239-42. PubMed ID: 16301549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrafamilial variability in Hurler syndrome and Sanfilippo syndrome type A: implications for evaluation of new therapies.
    McDowell GA; Cowan TM; Blitzer MG; Greene CL
    Am J Med Genet; 1993 Nov; 47(7):1092-5. PubMed ID: 7507293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional capacity evaluation of patients with mucopolysaccharidosis.
    Guarany NR; Schwartz IV; Guarany FC; Giugliani R
    J Pediatr Rehabil Med; 2012; 5(1):37-46. PubMed ID: 22543891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mucopolysaccharidoses: characterization by cranial MR imaging.
    Lee C; Dineen TE; Brack M; Kirsch JE; Runge VM
    AJNR Am J Neuroradiol; 1993; 14(6):1285-92. PubMed ID: 8279321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.